Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • June 12, 2026

    Explain to parents why Vitamin K administration at birth is a safe and effective means of preventing neonatal bleeding conditions. More parents are saying no to the shot due to misinformation.

    Medical Mythbusting Commentary for June 12, 2026 Source:More parents are saying no to newborn vitamin K shots. Experts are concerned. Reference: The following patient handout synthesizes the information discussed across this conversation, covering the rationale for vitamin K at birth, sources of vitamin K, types and symptoms of vitamin K deficiency bleeding, and the outcomes…

    tagged:

    Vitamin K
  • June 11, 2026

    Health sleuths are watching for disease threats during the World Cup. Measles is at the top of the list.

    Medical Mythbusting Commentary for June 11, 2026 Source:Health sleuths are watching for disease threats during the World Cup

    tagged:

    gastroenteritis, hepatitis A, measles, world cup
  • June 10, 2026

    Brain mechanism reveals in mice how food aroma primes metabolism and may explain obesity risk

    Medical Mythbusting Commentary for June 10, 2026 Source:Brain mechanism reveals how food aroma primes metabolism and may explain obesity risk Reference:Glycogen drives the sensory activation of POMC neurons

    tagged:

    appetite, food consumption, obesity
  • June 9, 2026

    Childhood egg allergies fall as early introduction becomes more common, new study finds

    Medical Mythbusting Commentary for June 9, 2026 Source:Childhood egg allergies fall as early introduction becomes more common, new study finds Reference:Guidelines for Early Food Introduction and Patterns of Food Allergy

    tagged:

    egg allergy, immunotherapy
  • June 8, 2026

    New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability

    Medical Mythbusting Commentary for June 8, 2026 Source:New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability Reference: A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome

    tagged:

    drug resistant bacteria
  • June 7, 2026

    House Calls, #1017, June 7, 2026: Bang the Drum!

    A new study reviews the impact of screentime on the brain development of children and adolescents and the imprinting of neurological changes that remain permanent and not in a good way. Summer season and the mosquitos are out. A review of DEET and alternatives especially for young children. Info below. Your Calls and Comments: Playlist…

    tagged:

    DEET, Ear wax, osteoarthritis, wait times
  • June 3, 2026

    The mechanism of why statin medications can cause muscles aches has been outlined but this pathway is found in a minority of patients so other reasons remain elusive.

    Medical Mythbusting Commentary for June 3, 2026 Source:A Painful Side Effect of Statins Explained After Decades of Mystery Reference:Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation

    tagged:

    muscle pain, statins
  • June 2, 2026

    Scientists using other animal species who have the capacity for ocular regeneration after injury to try to determine if similar pathways in people exist and if it can be stimulated to repair eye trauma.

    Medical Mythbusting Commentary for June 2, 2026 Source:Scientists Think They’ve Discovered How Humans Could Recover Lost Vision

    tagged:

  • June 1, 2026

    New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.

    Medical Mythbusting Commentary for June 1, 2026 Source:‘I actually started crying’: Oncologist reacts to pancreatic cancer drug results Synopsis of the article and study: Benefits: Doubled survival, oral convenience, targeted action, manageable side effects. Limitations: Grade 3+ adverse events in about one-third of patients; still experimental, not yet fully approved; tested in advanced cases post-chemo.

    tagged:

    pancreatic cancer
←Previous Page
1 2 3 4 5 … 599
Next Page→
  • Facebook
  • X